163 related articles for article (PubMed ID: 37312213)
1. Stereotactic ablative body radiation therapy for isolated pulmonary metastases from pancreatic cancer after metastectomy with positive margins: a case report.
Alnsour A; Le H; Byrne A; Rodgers N; Roos D
J Med Case Rep; 2023 Jun; 17(1):273. PubMed ID: 37312213
[TBL] [Abstract][Full Text] [Related]
2. Adrenal oligometastasis cured with stereotactic ablative radiotherapy.
Malone J; Pantarotto JR; Tiberi D; Malone S
Radiol Case Rep; 2020 Nov; 15(11):2266-2270. PubMed ID: 32983297
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of single fraction stereotactic ablative radiotherapy for lung metastases.
Filippi AR; Badellino S; Guarneri A; Levis M; Botticella A; Mantovani C; Ragona R; Racca P; Buffoni L; Novello S; Ricardi U
Technol Cancer Res Treat; 2014 Feb; 13(1):37-45. PubMed ID: 23819496
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Outcomes of Salvage Stereotactic Ablative Radiotherapy for Isolated Lung Recurrence of Non-Small Cell Lung Cancer: A Phase II Clinical Trial.
Sun B; Brooks ED; Komaki R; Liao Z; Jeter M; McAleer M; Balter PA; Welsh JD; O'Reilly M; Gomez D; Hahn SM; Sepesi B; Rice DC; Heymach JV; Chang JY
J Thorac Oncol; 2017 Jun; 12(6):983-992. PubMed ID: 28259750
[TBL] [Abstract][Full Text] [Related]
5. Curative intent Stereotactic Ablative Radiation Therapy (SABR) for treatment of lung oligometastases from head and neck squamous cell carcinoma (HNSCC): a multi-institutional retrospective study.
Debbi K; Loganadane G; To NH; Kinj R; Husain ZA; Chapet S; Nguyen NP; Barillot I; Benezery K; Belkacemi Y; Calais G
Br J Radiol; 2022 May; 95(1133):20210033. PubMed ID: 35143326
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic Ablative Radiation Therapy for Large (≥5 cm) Non-small Cell Lung Carcinoma.
McDermott RL; Mihai A; Dunne M; Keys M; O'Sullivan S; Thirion P; ElBeltagi N; Armstrong JG
Clin Oncol (R Coll Radiol); 2021 May; 33(5):292-299. PubMed ID: 33309479
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic ablative radiotherapy (SABR) as primary, adjuvant, consolidation and re-treatment option in pancreatic cancer: scope for dose escalation and lessons for toxicity.
Goldsmith C; Plowman PN; Green MM; Dale RG; Price PM
Radiat Oncol; 2018 Oct; 13(1):204. PubMed ID: 30340643
[TBL] [Abstract][Full Text] [Related]
8. Consolidative Radiotherapy for Limited Metastatic Non-Small-Cell Lung Cancer: A Phase 2 Randomized Clinical Trial.
Iyengar P; Wardak Z; Gerber DE; Tumati V; Ahn C; Hughes RS; Dowell JE; Cheedella N; Nedzi L; Westover KD; Pulipparacharuvil S; Choy H; Timmerman RD
JAMA Oncol; 2018 Jan; 4(1):e173501. PubMed ID: 28973074
[TBL] [Abstract][Full Text] [Related]
9. Isolated pulmonary metastases define a favorable subgroup in metastatic pancreatic cancer.
Kruger S; Haas M; Burger PJ; Ormanns S; Modest DP; Westphalen CB; Michl M; Kleespies A; Angele MK; Hartwig W; Bruns CJ; Niyazi M; Roeder F; Kirchner T; Werner J; Heinemann V; Boeck S
Pancreatology; 2016; 16(4):593-8. PubMed ID: 27067420
[TBL] [Abstract][Full Text] [Related]
10. Consolidative stereotactic ablative radiotherapy (SABR) to intrapulmonary lesions is associated with prolonged progression-free survival and overall survival in oligometastatic NSCLC patients: A prospective phase 2 study.
Blake-Cerda M; Lozano-Ruíz F; Maldonado-Magos F; de la Mata-Moya D; Díaz-García D; Lara-Mejía L; Zatarain-Barrón ZL; Cuevas-Góngora MF; Barron-Barron F; Corona-Cruz JF; Cabrera-Miranda L; Arroyo-Hernández M; Gerson R; Arrieta O
Lung Cancer; 2021 Feb; 152():119-126. PubMed ID: 33385737
[TBL] [Abstract][Full Text] [Related]
11. Results of a prospective phase 2 clinical trial of induction gemcitabine/capecitabine followed by stereotactic ablative radiation therapy in borderline resectable or locally advanced pancreatic adenocarcinoma.
Quan K; Sutera P; Xu K; Bernard ME; Burton SA; Wegner RE; Zeh H; Bahary N; Stoller R; Heron DE
Pract Radiat Oncol; 2018; 8(2):95-106. PubMed ID: 29291966
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary oligometastases: metastasectomy or stereotactic ablative radiotherapy?
Widder J; Klinkenberg TJ; Ubbels JF; Wiegman EM; Groen HJ; Langendijk JA
Radiother Oncol; 2013 Jun; 107(3):409-13. PubMed ID: 23773410
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of Stereotactic Ablative Radiotherapy for Systemic Therapy Respondents with Inoperable Pulmonary Oligometastases and Oligoprogression.
Ho CB; Tsai JT; Chen CY; Shiah HS; Chen HY; Ting LL; Kuo CC; Lai IC; Lai HY; Chung CL; Lee KL; Tzeng HE; Lee KH; Lee HL; Chen SW; Chiou JF
Diagnostics (Basel); 2023 Apr; 13(9):. PubMed ID: 37174988
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic ablative radiation therapy for pulmonary metastases: Improving overall survival and identifying subgroups at high risk of local failure.
Pasalic D; Lu Y; Betancourt-Cuellar SL; Taku N; Mesko SM; Bagley AF; Chance WW; Allen PK; Tang C; Antonoff MB; Balter PA; Mehran RJ; Welsh JW; Liao Z; Gomez D; Erasmus JJ; Nguyen QN
Radiother Oncol; 2020 Apr; 145():178-185. PubMed ID: 32044530
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic Ablative Body Radiotherapy (SABR) in Pulmonary Oligometastatic/Oligorecurrent Non-small Cell Lung Cancer Patients: A New Therapeutic Approach.
Agolli L; Valeriani M; Nicosia L; Bracci S; De Sanctis V; Minniti G; Enrici RM; Osti MF
Anticancer Res; 2015 Nov; 35(11):6239-45. PubMed ID: 26504057
[TBL] [Abstract][Full Text] [Related]
16. Increased efficacy of stereotactic ablative radiation therapy after bevacizumab in lung oligometastases from colon cancer.
Mazzola R; Tebano U; Aiello D; Paola GD; Giaj-Levra N; Ricchetti F; Fersino S; Fiorentino A; Ruggieri R; Alongi F
Tumori; 2018 Dec; 104(6):423-428. PubMed ID: 29737958
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic ablative body radiotherapy for lung cancer.
Franks KN; Jain P; Snee MP
Clin Oncol (R Coll Radiol); 2015 May; 27(5):280-9. PubMed ID: 25746732
[TBL] [Abstract][Full Text] [Related]
18. A Case of Metastatic Head and Neck Squamous Cell Carcinoma with Multiple Treatments Including Stereotactic Ablative Body Radiotherapy Alone for Oligometastases to the Parotid Gland.
Sharrett J; Pederson A
Cureus; 2015 Dec; 7(12):e438. PubMed ID: 26858919
[TBL] [Abstract][Full Text] [Related]
19. What Factors Are Associated with Treatment Outcomes of Japanese Patients with Clear Cell Chondrosarcoma?
Nakayama R; Hayakawa K; Kobayashi E; Endo M; Asano N; Yonemoto T; Kawashima H; Hamada K; Watanabe I; Futani H; Goto T; Nishida Y; Ozaki T
Clin Orthop Relat Res; 2020 Nov; 478(11):2537-2547. PubMed ID: 32297725
[TBL] [Abstract][Full Text] [Related]
20. Sinoatrial node toxicity after stereotactic ablative radiation therapy to lung tumors.
Qian Y; Zhu H; Pollom EL; Durkee BY; Chaudhuri AA; Gensheimer MF; Diehn M; Shultz DB; Loo BW
Pract Radiat Oncol; 2017; 7(6):e525-e529. PubMed ID: 28669706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
